Traws Pharma launches antiviral program targeting Hantavirus and Ebola outbreaks
Filed May 27, 2026 · Period ending May 27, 2026 · ~1 min read
2 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade TRAW commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
View original filing on SEC.gov
Generated by AI · May 27, 2026 10:05 PM